呼吸器感染症に対するCefotiam (SCE-963) の臨床効果の検討

抄録

Cefotiam (SCE-963), a new cephalosporin antibiotic, was given to 6 cases with respiratory tracd infections (4 pneumonia including 1 PAP, 1 bronchiectasis and 1 pulmonary abscess). Dosage of cefotiam was 1.0-3.0 g twice a day by intravenous drip infusion.
Clinical responses were excellent in 3 cases, good in 1 and failure in 2 (PAP and bronchiectasis).
Skin test for hypersensitivity to cefotiam demonstrated no positive reactions but itching was observed as a side effect in 1 case.